Instructions to Authors

Manuscripts submitted for publication in the Mediterranean Journal of Pharmacy and Pharmaceutical Sciences (Mediterr J Pharm Pharm Sci) can be review articles, original articles, or short communications. The manuscript should carefully be prepared, double-spaced, and pages numbered. Generally, original articles should not exceed 3500 words or 10 printed pages.

Submitted manuscripts should be accompanied by a letter from the corresponding author indicating that no part of the submitted work has previously been published (in print or electronic format) or is not under simultaneous consideration by another publication or electronic medium. Under no circumstances will any manuscript be considered for publication in Mediterr J Pharm Pharm Sci that contains any data that have been published or submitted for publication elsewhere.

Manuscripts reporting studies involving human subjects must be accompanied by a statement from the main author confirming that informed consent was obtained from all subjects involved. This statement must also appear in the materials and methods section of the manuscript. Manuscripts reporting studies involving live animals (vertebrates) must be accompanied by a statement from the main author confirming that experiments were performed by relevant international guidelines and regulations.

The contents of the manuscript should be arranged under the following headings: Abstract, Introduction, Materials and methods, Results, Discussion, Conclusion, Acknowledgements, Funding, Conflict of Interest, References, Figures, and Tables.

The first page should comprise: The title of the paper, name(s) of the author(s), Affiliations, and the exact contact information of the corresponding author must be given in detail at the end of the page. Title: should occupy no more than three lines. The title should convey the conceptual significance of the paper to a broad readership. Authors/Affiliations: The author name(s) should be written as (Ali M. Zorgani). Affiliations should contain the following core information: department(s), institution(s), city, and country. Contact Information: The contact line should include the e-mail address and phone number of the corresponding author.

Abstract: This should be composed of a single paragraph of no more than 250-300 words. It should contain a brief background of the question, a description of the results without extensive experimental details, and a summary of the significance of the findings. Keywords between 5-8 words related directly to the manuscript followed by the abstract section.

Introduction: should be concise, with no subheadings and should present the background information necessary to provide a logical context for the results.

Materials and methods: This section needs to include sufficient details so that readers can understand how the experiments were carried out. Ethics approval from the organization should be cited here. This section should also include a description of the statistical methods, if any, employed in the study.

Results: This section should be divided into subheadings, so the reader can follow the logic of results development.

Discussion: should explain the significance of the results and place them into a broader context. It should not be redundant with the Results section. A conclusion should be given as a separate following discussion.

References: should include only articles that are published or preprinted. Please use the following style for references: References in the text should be numbered consecutively in their order of appearance. "Unpublished observations" and "personal communications" may not be used as references but may be inserted in parentheses in the text.

The reference list format is as follows:

    1. Sherif FM (2023) The future of pharmacy in Libya. Mediterr J Pharm Pharm Sci. 3 (1): 1-2. doi: 10:5281.zenodo.7771304
    2. Ramadan MA (1995) Structure of cell wall. In: Molecular biology. 2nd ed, 567-574. UoT press, Libya. ISBN: 2154-2458-2654.

Use system international (SI) measurements throughout the manuscript. Use generic names of drugs, unless the trade name is directly relevant to the discussion. Acknowledge all illustrations and tables or long annotations taken from other publications and submit written permission to reprint from the original publishers.

Do not use abbreviations in the title or abstract section.

All submissions are initially evaluated by the editorial board. Papers that do not conform to the general format mentioned above will be returned to the authors for reformatting prior to review. Papers not accepted before refereed are returned within two weeks of acknowledgment of receipt. Encouraging papers are refereed by two referees in addition to a statistical referee if needed and if not accepted are returned within two weeks. Papers accepted are sent back for revision based on comments received. Authors should give such revision priority and reciprocate with the journal to take a final decision by sending back the revised version and one of them should annotate to show where changes have been made within two weeks. Also, provide a cover letter indicating detailed responses to the reviewer’s comments. Resubmission to the Journal for reevaluation is open as soon as all the guidelines have been considered.

Authors are advised to keep raw data stored for up to five years because at any time after the publication of a research paper, you may be asked to submit these data to MJPPS.

Use the "MANUSCRIPT SUBMISSION" to submit your manuscript. Correspondence should be addressed to the editor-in-chief.